Govt fixes trade margins of over 40 costly cancer drugs
The minister informed the House that the MRPs of these cancer medicines have been capped in such a manner that it cannot be more than 60 percent of the first price that a manufacturer sells to a distributor in India.
New Delhi: The government has fixed trade margins of over 40 costly cancer drugs following which prices have come down significantly, Union Health Minister Mansukh Mandaviya informed the Rajya Sabha on Tuesday. Replying to supplementaries during the Question Hour, the minister also said India now has the capability to manufacture cancer treatment drugs, which are otherwise imported.
Ruchika joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at firstname.lastname@example.org Contact no. 011-43720751